Real-Time Imaging of Brain Tumor for Image-Guided Surgery

Adv Healthc Mater. 2018 Aug;7(16):e1800066. doi: 10.1002/adhm.201800066. Epub 2018 May 2.

Abstract

The completion of surgical resection is a key prognostic factor in brain tumor treatment. This requires surgeons to identify residual tumors in theater as well as to margin the proximity of the tumor to adjacent normal tissue. Subjective assessments, such as texture palpation or visual tissue differences, are commonly used by oncology surgeons during resection to differentiate cancer lesions from normal tissue, which can potentially result in either an incomplete tumor resection, or accidental removal of normal tissue. Moreover, malignant brain tumors are even more difficult to distinguish from normal brain tissue, and resecting noncancerous tissue may create neurological defects after surgery. To optimize the resection margin in brain tumors, a variety of intraoperative guidance techniques are developed, such as neuronavigation, magnetic resonance imaging, ultrasound, Raman spectroscopy, and optical fluorescence imaging. When combined with appropriate contrast agents, optical fluorescence imaging can provide the neurosurgeon real-time image guidance to improve resection completeness and to decrease surgical complications.

Keywords: brain tumors; contrast agents; image-guided therapy; intraoperative imaging; real-time imaging.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / surgery*
  • Humans
  • Magnetic Resonance Imaging
  • Optical Imaging
  • Photosensitizing Agents
  • Surgery, Computer-Assisted / methods*

Substances

  • Photosensitizing Agents